Extended adjuvant treatment of patients with HER2+ early breast cancer with neratinib: a multi-centric, prospective, non-interventional study (NIS) in Germany and Austria (ELEANOR)

• R. Bartsch,
• D. Lüftner,
• M. Balic,
• G. Rinnerthaler,
• C. Jackisch,
• V. Müller,
• M. Schmidt,
• N. Harbeck

Affiliations

R. Bartsch

D. Lüftner

M. Balic

G. Rinnerthaler

C. Jackisch

V. Müller

M. Schmidt

N. Harbeck